ALT 10-Q: SEC filing
Altimmune, Inc.
Filed with the SEC on · accession 0001326190-26-000070
ALT filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -16.6% by the first close after the filing.
Summary of the filing
Altimmune, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing recent financing activities including registered direct offerings and an at-the-market offering program.
Key details
How ALT stock reacted
Close before
$1.93
Nov 11, 2026
First close after
-16.58%
$1.61
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ALT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ALT?
Click hereFrequently asked questions
What did ALT file with the SEC on Nov 12, 2026?
ALT filed a 10-Q (SEC filing). Altimmune, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosing recent financing activities including registered direct offerings and an at-the-market offering program.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did ALT stock react to this filing?
ALT closed at $1.93 before the filing and $1.61 on Nov 12, 2026 (-16.58%).
Other ALT SEC filings
- 8-K · SEC filingNov 12, 2026
- SCHEDULE 13G · SEC filingNov 10, 2026
- 8-K · Material agreementOct 29, 2026
- 8-K · SEC filingOct 27, 2026
- 8-K · Executive departureSep 29, 2026
- 8-K · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 12, 2026
- 8-K · Fda approvalJul 28, 2026
- 8-K · SEC filingJun 16, 2026
- 10-Q · SEC filingMay 13, 2026
Get alerts when ALT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days